Detalhe da pesquisa
1.
SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: results from the real world PROPHESYS study.
Ann Hepatol
; 13(2): 303-4, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24558225